| NCT06939283 | A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma | RECRUITING | PHASE1, PHASE2 | 2025-05-07 | 2028-08 | 2028-08 |
| NCT05678998 | WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma | COMPLETED | PHASE1 | 2022-12-06 | 2025-02-05 | 2024-10-18 |
| NCT05479812 | Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1 | 2022-05-20 | 2026-07-31 | 2026-07-01 |